1st Quarter - Amendment

ELI LILLY AND COMPANY for ELI LILLY AND COMPANY

Firm
Client
Income
—
Expenses
$1,840,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 19, 2021 $1,840,000 Replaced
1st Quarter - Amendment (this page) Apr 19, 2021 $1,840,000 Yes

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Intellectual property; 340B Program; PPACA; Medicare & Medicaid prescription drug reimbursement, coverage and value; Developing an Innovative Strategy for Antimicrobial Resistant Microorganism Act of 2019 (DISARM Act); American Rescue Plan Act, 2021 (HR.1319)

LobbyistCovered position, as disclosed
SARAH KYLE —
SHAWN O'NEAIL New —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Office of Management & Budget (OMB); State, Dept of (DOS); Homeland Security, Dept of (DHS); Justice, Dept of (DOJ); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1319 (117th)

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Puerto Rico tax issues; Pension and retirement benefit issues

LobbyistCovered position, as disclosed
SARAH KYLE —
THOMAS CORDREY ROBERGE —
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); Homeland Security, Dept of (DHS); Commerce, Dept of (DOC); Justice, Dept of (DOJ); State, Dept of (DOS); Health & Human Services, Dept of (HHS); SENATE; U.S. Trade Representative (USTR); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Pharmaceutical intellectual property issues

LobbyistCovered position, as disclosed
SARAH KYLE —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: Justice, Dept of (DOJ); State, Dept of (DOS); Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE; Homeland Security, Dept of (DHS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Consumer Issues/Safety/Products CSP

Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value and access

LobbyistCovered position, as disclosed
SARAH KYLE —
SHAWN O'NEAIL New —
THOMAS CORDREY ROBERGE —
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); Food & Drug Administration (FDA); State, Dept of (DOS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Commerce, Dept of (DOC); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Saudi Arabia; Mexico patent linkage; Special 301; Trade talks: US-Japan, US-China, US-EU, US-UK, US-Kenta, and US-Brazil

LobbyistCovered position, as disclosed
PAUL BURKHEAD —
HEATHER CLARK New —
SARAH KYLE —
SHAWN O'NEAIL New —
THOMAS CORDREY ROBERGE —
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: SENATE; Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); Justice, Dept of (DOJ); Executive Office of the President (EOP); Commerce, Dept of (DOC); State, Dept of (DOS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Health Issues HCR

Patient protection; Drug supply chain and shortages; Drug pricing, value and access; Transparency; Intellectual property; Health insurance accessibility; "Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act"; American Rescue Plan Act, 2021 (HR.1319)

LobbyistCovered position, as disclosed
SARAH KYLE —
SHAWN O'NEAIL New —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: Office of Management & Budget (OMB); Justice, Dept of (DOJ); State, Dept of (DOS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); SENATE; Commerce, Dept of (DOC); Executive Office of the President (EOP)

Bills named: H.R. 1319 (117th)

Immigration IMM

Administration Immigration Proclamation on non-immigrant visa categories

LobbyistCovered position, as disclosed
SARAH KYLE —
SHAWN O'NEAIL —
THOMAS CORDREY ROBERGE Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Justice, Dept of (DOJ); Commerce, Dept of (DOC); Homeland Security, Dept of (DHS); U.S. Trade Representative (USTR); SENATE; Office of Management & Budget (OMB)

Pharmacy PHA

Hospital discounts; 340B program

LobbyistCovered position, as disclosed
SARAH KYLE —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)
SHANNON STEHOUWER New Staff, Senator John Hoeven (2014-2016) Staff, Rep. Mike Rogers (2010-2014)

Contacted: U.S. Trade Representative (USTR); Executive Office of the President (EOP); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Homeland Security, Dept of (DHS); Justice, Dept of (DOJ)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.